Benzinga | Jan 4, 2022 06:39AM EST

Piper Sandler Downgrades Zimmer Biomet Holdings to Neutral, Lowers Price Target to $135

Piper Sandler analyst Matt O'Brien downgrades Zimmer Biomet Holdings (NYSE:ZBH) from Overweight to Neutral and lowers the price target from $185 to $135.